Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis
Xiaobei Pan(Queen's University Belfast), Joseph Kane(University of Ulster), John T. O’Brien(North Tyneside General Hospital), Alan Thomas(Cleveland Clinic), Gemma Roberts(Newcastle University), Bernadette McGuinness(Queen's University Belfast), Amanda Heslegrave(UK Dementia Research Institute), Henrik Zetterberg(University of Wisconsin–Madison), Paul C. Donaghy(Cleveland Clinic), Brian D. Green(University of Georgia), Anthony Peter Passmore(Queen's University Belfast), Leonidas Chouliaras(University of Cambridge)
Cited by 7
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k